JPS6360944A - Optical resolution of lignans - Google Patents
Optical resolution of lignansInfo
- Publication number
- JPS6360944A JPS6360944A JP20532986A JP20532986A JPS6360944A JP S6360944 A JPS6360944 A JP S6360944A JP 20532986 A JP20532986 A JP 20532986A JP 20532986 A JP20532986 A JP 20532986A JP S6360944 A JPS6360944 A JP S6360944A
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- chromatography
- lignans
- derivative
- adsorbent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930013686 lignan Natural products 0.000 title claims abstract description 22
- 235000009408 lignans Nutrition 0.000 title claims abstract description 22
- 150000005692 lignans Chemical class 0.000 title claims abstract description 21
- 230000003287 optical effect Effects 0.000 title claims abstract description 20
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 34
- 239000005017 polysaccharide Substances 0.000 claims abstract description 34
- 239000003463 adsorbent Substances 0.000 claims abstract description 19
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 150000004676 glycans Chemical class 0.000 claims abstract 4
- 238000000034 method Methods 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 abstract description 10
- 238000004811 liquid chromatography Methods 0.000 abstract description 8
- 229920002678 cellulose Polymers 0.000 abstract description 5
- 239000001913 cellulose Substances 0.000 abstract description 5
- 239000002245 particle Substances 0.000 abstract description 5
- -1 polysaccharide ester Chemical class 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 238000004817 gas chromatography Methods 0.000 abstract description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract description 2
- 239000003905 agrochemical Substances 0.000 abstract description 2
- 239000010409 thin film Substances 0.000 abstract 1
- 150000004804 polysaccharides Chemical class 0.000 description 28
- 239000002904 solvent Substances 0.000 description 11
- 229920005610 lignin Polymers 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000002023 wood Substances 0.000 description 6
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 2
- 229960001237 podophyllotoxin Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229930189508 virginol Natural products 0.000 description 2
- VJOBNGRIBLNUKN-BMHXQBNDSA-N (+)-Medioresinol Natural products C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 VJOBNGRIBLNUKN-BMHXQBNDSA-N 0.000 description 1
- VJOBNGRIBLNUKN-UHFFFAOYSA-N (+)-medioresinal Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 VJOBNGRIBLNUKN-UHFFFAOYSA-N 0.000 description 1
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical group C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 1
- VJOBNGRIBLNUKN-ITZZLVQVSA-N 4-[(3s,3ar,6ar)-3-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H](C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 VJOBNGRIBLNUKN-ITZZLVQVSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- NFHFNBFYZIJLKZ-UHFFFAOYSA-N Asarinin Natural products CC1(OCC2C1COC2c3ccc4OCOc4c3)c5ccc6OCOc6c5 NFHFNBFYZIJLKZ-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZGLXUQQMLLIKAN-UHFFFAOYSA-N Deoxypicropodophyllin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3CC3C2C(OC3)=O)=C1 ZGLXUQQMLLIKAN-UHFFFAOYSA-N 0.000 description 1
- 241000490050 Eleutherococcus Species 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241001483078 Phyto Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- ZGLXUQQMLLIKAN-SVIJTADQSA-N deoxypodophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3C[C@@H]3[C@@H]2C(OC3)=O)=C1 ZGLXUQQMLLIKAN-SVIJTADQSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- VDCSGNNYCFPWFK-UHFFFAOYSA-N diphenylsilane Chemical compound C=1C=CC=CC=1[SiH2]C1=CC=CC=C1 VDCSGNNYCFPWFK-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 125000000686 lactone group Chemical group 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920005640 poly alpha-1,3-glucan Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はリグナン類の光学異性体(エナンチオマー)混
合物から、各々のエナンチオマーを単離する方法に関す
るものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for isolating each enantiomer from a mixture of optical isomers (enantiomers) of lignans.
不斉な化合物の光学異性体はその生理作用を異にするこ
とが普通であり、従って医農薬等においては、一方のエ
ナンチオマーのみを用いることが副作用の除去、或いは
単位当たり薬効の改善につながる場合がある。また最近
では液晶その他の光学材料に光学活性物質を用いること
も検討され始めている。こうした事情から光学活性物質
の合成或いは単離が有機合成化学の関心事になりつつあ
る。Optical isomers of asymmetric compounds usually have different physiological actions, and therefore, in medicines and agrochemicals, the use of only one enantiomer may eliminate side effects or improve the medicinal efficacy per unit. There is. Recently, studies have also begun to consider the use of optically active substances in liquid crystals and other optical materials. Under these circumstances, the synthesis or isolation of optically active substances is becoming an area of interest in organic synthetic chemistry.
本発明が光学分割の対象とするリグナン類は各種の植物
の組織内に光学活性体として存在する物質であり、しば
しば配糖体として得られる。The lignans targeted for optical resolution in the present invention are substances that exist as optically active substances in the tissues of various plants, and are often obtained as glycosides.
これらリグナン類、或いはその配糖体には生理活性を有
するものが多く、和漢薬の有効成分と考えられているも
のもあるが、その生産量は小さい。Many of these lignans or their glycosides have physiological activity, and some are considered to be active ingredients in Japanese and Chinese medicine, but their production volumes are small.
他方、リグナン類は例えば次式
で表される骨格を有するアルコールの酸化的カップリン
グ〔天然物化学、 K、B、G トーセル著。On the other hand, lignans can be used, for example, by oxidative coupling of alcohols having a skeleton represented by the following formula [Natural Product Chemistry, K., B., G. Thorsell.
野副重男、三用潮訳、 PIOI〜105 (1984
) ;リグニンの化学−基礎と応用、中野準三編、 P
80〜91 (1979) )もしくはリグニンの分解
〔リグニンの化学−基礎と応用、中野準三m、 P11
3〜129(1979) )等の方法によりそのラセミ
体を多量に得ることができる。従ってこれを光学分割す
ることができるなら、より多量のりダナン類を供給する
ことができ、更にこれにグリコジル化反応を行えばリグ
ナン配糖体を得ることができる。Shigeo Nozoe, translated by Ushio Sanyo, PIOI~105 (1984)
) ; Chemistry of lignin - basics and applications, edited by Junzo Nakano, P
80-91 (1979)) or decomposition of lignin [Lignin chemistry - basics and applications, Junzo Nakano, P11
3-129 (1979)), the racemate can be obtained in large quantities. Therefore, if this can be optically resolved, a larger amount of dananes can be supplied, and if this is further subjected to a glycosylation reaction, lignan glycosides can be obtained.
しかしこのリグナン類を効果的に光学分割する方法はな
かった。However, there was no method to effectively optically resolve these lignans.
本発明者らは前項で述べたリグナ、ン頚もしくはその配
糖体を製造する上での問題点に鑑み、簡便で工業化が容
易であるような光学分割の方法を検討した結果、多糖の
誘導体を有効成分とする吸着剤による吸着を利用した分
離方法がこれらの化合物の光学分割に適していることを
見出し、本発明を完成するに至った。In view of the problems in producing liguna, ligna, or their glycosides as described in the previous section, the present inventors investigated a method of optical resolution that is simple and easy to industrialize. The present inventors have discovered that a separation method utilizing adsorption with an adsorbent containing as an active ingredient is suitable for the optical resolution of these compounds, and have completed the present invention.
即ち本発明は、リグナン類光学異性体の混合物を多糖誘
導体を有効成分とする吸着剤を用いてクロマトグラフィ
ーにより光学分割することを特徴とするリグナン類の光
学分割方法に関するものである。That is, the present invention relates to a method for optically resolving lignans, which comprises optically resolving a mixture of optical isomers of lignans by chromatography using an adsorbent containing a polysaccharide derivative as an active ingredient.
本発明が光学分割の対象とするところのりダナン類は、
下記(A) 、 (B) 、 (C)或いは(D)Ar
’−C−C−C
l (A)
Ar−C−C−C
(Ar又はAr″は芳香環残基を示す。x7は単数もし
くは複数の置換基であり、−011,−0CH3゜−0
−C11□−〇−などが一般的である。nは1〜3の
0数で、n個のXはそれぞれ異なっても良い。)で
表される基本骨格を有する一群の化合物である。但し、
本発明においては天然物、合成物を問わず、不斉中心を
その中に含む環状構造を有する化合物に対象を限定する
。即ち、少し具体的に述べるなら、(C)のクマラン骨
格を有する化合物、及び(A)のいわゆるβ−β結合を
有する化合物のうち、下記の(E)〜(りで示すような
環状構造を有するものが多く知られている。The glue Dananes that are the subject of optical resolution in the present invention are:
The following (A), (B), (C) or (D) Ar
'-C-C-C l (A) Ar-C-C-C (Ar or Ar'' represents an aromatic ring residue. x7 is a single or multiple substituent, -011, -0CH3゜-0
-C11□-〇- etc. are common. n is 1 to 3
The n number of X's may be 0 and may be different from each other. ) is a group of compounds having a basic skeleton represented by however,
The present invention is limited to compounds having a cyclic structure containing an asymmetric center, regardless of whether they are natural or synthetic. That is, to be more specific, among compounds having a coumaran skeleton (C) and compounds having a so-called β-β bond (A), compounds having a cyclic structure as shown in the following (E) to (ri) Many are known to have it.
(E) (F) (G、レジノ
ール骨々(H) (I)(*
は不斉中心を示す。)
Ar、Ar’はいかなる芳香族基であってもよいが、(
然のリグナン類においては次式
ご示したようなものが一般的である。(E) (F) (G, Resinol bones (H) (I) (*
indicates an asymmetric center. ) Ar, Ar' may be any aromatic group, but (
Among natural lignans, the one shown in the following formula is common.
以下にリグナン類の具体的な化合物を例示すもと、
nl
ビルジノール(2)
セサミン(4)
メディオレジノール
エピピルレジノール
CHz
ポドフィロトキシン(5)
CR1
デオキシポドフィロトキシン
H
α−ペルタチン
ブルセラン
ッヤプリ力チン
等を挙げることができる(リグナン類に関する解説;中
野準三、樋ロ隆昌、住本昌之9石津敦「木材化学」ユニ
出版、昭58、右田伸彦、米沢保正、近藤民雄「木材化
学」下、共立出版、昭43)。Specific examples of lignan compounds are listed below: nl Virginol (2) Sesamin (4) Medioresinol Epipyresinol CHz Podophyllotoxin (5) CR1 Deoxypodophyllotoxin H α-pertatin (Commentary on lignans; Junzo Nakano, Takamasa Hiro, Masayuki Sumimoto 9 Atsushi Ishizu "Wood Chemistry" Uni Publishing, 1982, Nobuhiko Migita, Yasumasa Yonezawa, Tamio Kondo) “Wood Chemistry” Volume 2, Kyoritsu Shuppan, 1972).
リグナン類の中には薬理作用などの生理活性を持つもの
が数多く見出されている。これに関してはW、D、Mc
Rae、 G、11.N、Towers、 Phyto
chemi−stry、 23.1207 (1984
)等に紹介されているので、あらためて詳しく触れるこ
とはしないが、いくつかを例示する。シリンガレシノー
ル(1)の配糖体はエゾウコギより抽出される強壮成分
エレウテロコックの有効成分として、外部からのストレ
ス、疲労に対する耐性を増大するといわれる。ビルジノ
ール(2)の配糖体は漢方の薬草Euco++uwia
ulmoidesより単離され、高血圧に有効である
といわれる。アサリニン(3)には抗結核作用が認めら
れ、またそのエピマーであるセサミン(4)と共にキク
酸系殺虫剤の薬効を増進する作用を有する。ポドフィロ
トキシン(5)及びその関連物質は抗ui活性を有する
ことでよく知られている。その他、中枢神経の興奮、抑
制、強心、その他多様な生理活性が各種のりダナン頻に
認められている。またその生理活性が光学異性体間で異
なる例もいくつか知られている。Many lignans have been found to have physiological activities such as pharmacological effects. Regarding this, W, D, Mc
Rae, G., 11. N.Towers, Phyto
Chemi-stry, 23.1207 (1984
) etc., so I will not go into details again, but I will give some examples. Glycosides of syringaresinol (1) are said to increase resistance to external stress and fatigue as an active ingredient of eleutherococcus, a tonic component extracted from Eleuthero. The glycoside of virginol (2) is derived from the Chinese herbal herb Euco++uwia.
ulmoides and is said to be effective for hypertension. Asarinin (3) has been shown to have an antituberculous effect, and together with its epimer, sesamin (4), has the effect of enhancing the efficacy of quilic acid insecticides. Podophyllotoxin (5) and its related substances are well known to have anti-UI activity. In addition, various physiological activities such as central nervous excitement, inhibition, cardiotonicity, and so on are frequently observed in various types of drugs. There are also some known examples in which the physiological activity differs between optical isomers.
これらリグナン類のラセミ体は通常の化学合成によって
得ることができるが、特にある種のリグナン類のラセミ
体は次式
で表されるアルコールを第二鉄イオンもしくはペルオキ
シダーゼの存在下に過酸化水素によって酸化すること(
文献;に、V、 5arkanen、 C,Il。Racemic forms of these lignans can be obtained by ordinary chemical synthesis, but in particular racemic forms of certain lignans can be obtained by converting the alcohol represented by the following formula into hydrogen peroxide in the presence of ferric ions or peroxidase. To oxidize (
References: V, 5arkanen, C, Il.
” d%4i g m +“Lignins”、 P1
16〜163(1971)、 WileyInters
cience ;中野準三m”リグニンの化学−基礎と
応用−” P2O,昭54.二二広報にK ; M、T
ana−hashi、 H,Takeuchi、 T、
Higuchi、 Wood Res、+ 6L44〜
53(1976)) 、リグニンを加水分解すること(
同、“Lignins”、 P345〜372 i同
、“リグニンの化学−基礎と応用−’ 、 pH3〜1
29 ; H,Naka−Lsubo、 M、Ta
nahashi+ T、lIiguchi、 Wo
od、 Res、+刹39〜18(1972)) 、
又は木材を高温高圧下に水藩気処理し、急激に常圧に戻
してその構造を破砕するいわゆる爆砕処理においてもリ
グニンの分解産物として(棚橋、樋ロ、祇パ技協誌。” d%4i g m + “Lignins”, P1
16-163 (1971), WileyInters
science ; Junzo Nakano "Chemistry of lignin - Basics and Applications -" P2O, 1974. K for 22 public relations; M, T
ana-hashi, H., Takeuchi, T.
Higuchi, Wood Res, +6L44~
53 (1976)), hydrolyzing lignin (
Ibid., "Lignins", P345-372 i Ibid., "Lignin Chemistry - Basics and Applications", pH 3-1
29; H, Naka-Lsubo, M, Ta
nahashi+ T, Iiguchi, Wo
od, Res, + 39-18 (1972)),
Also, in the so-called blasting process in which wood is treated with water and air under high temperature and pressure, and then rapidly returned to normal pressure to crush its structure, lignin decomposition products are produced (Tanahashi, Hiro, Gipa Gikyo Journal).
皿、、118〜127 (1985) ;同、祇パ技術
タイムス。Sara, 118-127 (1985); same, Gipa Technology Times.
邦(7)、1〜5 (1985) ;棚橋、小林、樋口
、第35回日本木材学会、研究発表要旨、 P288
(1985年4月);棚橋、樋ロ、第36回日本木材学
会、研究発表要旨、 P2O3(1986年4月))、
それぞれ、ラセミ体のリグナンが多量に生成することが
知られている。Kuni (7), 1-5 (1985); Tanahashi, Kobayashi, Higuchi, 35th Japan Wood Science Society, research presentation abstract, P288
(April 1985); Tanahashi, Hiro, 36th Japan Wood Society, Research Presentation Abstracts, P2O3 (April 1986)),
It is known that racemic lignans are produced in large quantities in each case.
本発明に用いられる吸着剤は多糖及びその誘導体を有効
成分とするものである。ここでいう多糖とは合成多糖、
天然多糖、天然物変成多糖のいずれかを問わず、光学活
性であればいかなるものでも良いが、好ましくは規則性
の高いホモグリカンであり、しかも結合様式も一定であ
るものである。更に好ましくは高純度の多糖を容易に得
ることのできるセルロース、アミロース、β−1,4−
キトサン、キチン、β−1,4−マンナン、β−1,4
−キシラン、イヌリン、α−1,3〜グルカン、β−L
3−グルカン等である。多糖の誘導体とは、上記多糖の
有する水酸基上の水素原子の一部あるいは全部、好まし
くは85%以上を他の原子団で置換したものである。The adsorbent used in the present invention contains polysaccharides and derivatives thereof as active ingredients. The polysaccharide referred to here is a synthetic polysaccharide,
Any optically active polysaccharide may be used, regardless of whether it is a natural polysaccharide or a polysaccharide modified from a natural product, but preferably a homoglycan with high regularity and a constant bonding pattern. More preferably, cellulose, amylose, β-1,4- from which highly purified polysaccharides can be easily obtained.
Chitosan, chitin, β-1,4-mannan, β-1,4
-xylan, inulin, α-1,3-glucan, β-L
3-glucan, etc. A polysaccharide derivative is one in which some or all, preferably 85% or more, of the hydrogen atoms on the hydroxyl groups of the polysaccharide are replaced with other atomic groups.
ここでいう原子団としては、
で表される基が挙げられ、R1は炭素数1乃至3より成
る脂肪族基、3乃至8より成る環式脂肪族基、炭素数4
乃至20より成る芳香族基もしくはヘテロ芳香族基であ
り、いずれも置換基を有しても良い、これらのmR体は
公知の各種の化学反応を用いて容易に得ることができる
。これら多糖及びその誘導体は原料の入手し易さ、安定
性などのゆえに工業的なりロマトグラフィー分離には特
に適したものである。これらの中で最も有効な吸着剤の
例としてはセルローストリスフェニル力ルバメートを挙
げることができる。Examples of the atomic group here include a group represented by the following, where R1 is an aliphatic group having 1 to 3 carbon atoms, a cycloaliphatic group having 3 to 8 carbon atoms, and a cycloaliphatic group having 4 carbon atoms.
The mR form of these aromatic groups or heteroaromatic groups, each of which may have a substituent, can be easily obtained using various known chemical reactions. These polysaccharides and their derivatives are particularly suitable for industrial chromatographic separation because of their ease of raw material availability and stability. An example of the most effective adsorbent among these is cellulose trisphenyl rubbermate.
本発明の光学分割、方法では、これら多糖又はその誘導
体の中から適当なものを選ぶことにより、目的とするリ
グナン類の光学分割を行うことができる。In the optical resolution method of the present invention, target lignans can be optically resolved by selecting an appropriate polysaccharide or derivative thereof from among these polysaccharides or derivatives thereof.
上記吸着剤を用いて本発明の光学活性体を得るための手
段としてはガスクロマトグラフィー、液体クロマトグラ
フィー、薄層クロマトグラフィー法などのクロマトグラ
フィー法がある。Examples of means for obtaining the optically active substance of the present invention using the above adsorbent include chromatography methods such as gas chromatography, liquid chromatography, and thin layer chromatography.
本発明に係わる吸着剤を液体クロマト法又はガスクロマ
ド法として使用するには、多糖又はその誘導体をそのま
まカラムに充填するか担体に保持させて充填するかキャ
ピラリーカラムにコーティングすることによっても使用
できる。In order to use the adsorbent according to the present invention in a liquid chromatography method or a gas chromatography method, the polysaccharide or its derivative can be packed into a column as it is, held on a carrier and packed therein, or coated on a capillary column.
クロマト用吸着剤は粒状であることが好ましいことから
、多糖又はその誘導体を化合物の吸着剤として用いるに
は、多糖又はその誘導体を破砕するか、ビーズ状にする
ことが好ましい。Since the adsorbent for chromatography is preferably in the form of particles, in order to use the polysaccharide or its derivative as an adsorbent for a compound, it is preferable to crush the polysaccharide or its derivative or make it into beads.
粒子の大きさは使用するカラムやプレートの大きさによ
って異なるが、1−〜10+wm、好ましくは1−〜3
00−であり、粒子は多孔質であることが好ましい。The particle size varies depending on the size of the column and plate used, but is 1-10+wm, preferably 1-3wm.
00-, and the particles are preferably porous.
更に吸着剤の耐圧能力の向上、溶媒置換による膨潤、収
縮の防止、理論段数の向上のために、多糖又はその誘導
体は担体に保持させることが好ましい。適当な担体の大
きさは、使用するカラムやプレートの大きさにより変わ
るが、−Cに1−〜1Ofl111であり、好ましくは
1 x〜300utmである。担体は多孔質であること
が好ましく、平均孔径はlO人〜100nであり、好ま
しくは50人〜10000人である。多糖又はその誘導
体を保持させる量は担体に対して1〜100重量%、好
ましくは5〜50重量%である。Further, in order to improve the pressure resistance of the adsorbent, prevent swelling and shrinkage due to solvent substitution, and increase the number of theoretical plates, it is preferable that the polysaccharide or its derivative be retained on a carrier. The appropriate size of the carrier varies depending on the size of the column and plate used, but it is 1 to 1 Ofl111 for -C, preferably 1 x to 300 utm. The carrier is preferably porous, with an average pore size of 10 to 100 nm, preferably 50 to 10,000. The amount of polysaccharide or its derivative retained is 1 to 100% by weight, preferably 5 to 50% by weight, based on the carrier.
多糖又はその誘導体を担体に保持させる方法は化学的方
法でも物理的方法でも良い。物理的方法としては、多糖
又はその誘導体を可溶性の溶剤に溶解させ、担体と良く
混合し、減圧又は加温下、気流により溶剤を留去させる
方法や、多糖又はその誘導体を可溶性の溶剤に溶解させ
、担体と良く混合した後、該溶剤と相溶性のない液体中
に攪拌、分散せしめ、該溶剤を拡散させる方法もある。The method for retaining the polysaccharide or its derivative on the carrier may be either a chemical method or a physical method. Physical methods include dissolving the polysaccharide or its derivative in a soluble solvent, mixing well with the carrier, and distilling off the solvent with air flow under reduced pressure or heating, or dissolving the polysaccharide or its derivative in a soluble solvent. There is also a method of dispersing the solvent by stirring and dispersing it in a liquid that is incompatible with the solvent after thoroughly mixing it with a carrier.
このようにして担体に保持した多糖又はその誘導体を結
晶化する場合には熱処理などの処理を行うことができる
。又、少量の溶剤を加えて多糖又はその誘導体を一旦膨
潤あるいは溶解せしめ、再び溶剤を留去することにより
その保持状態、ひいては分離能を変化せしめることが可
能である。When crystallizing the polysaccharide or its derivative held on the carrier in this way, a treatment such as heat treatment can be performed. Furthermore, by adding a small amount of solvent to once swell or dissolve the polysaccharide or its derivative, and then distilling off the solvent again, it is possible to change the retention state and, ultimately, the separation ability.
担体としては、多孔質有機担体又は多孔質無機担体があ
り、好ましくは多孔質無機担体である。多孔質有機担体
として適当なものは、ポリスチレン、ポリアクリルアミ
ド、ポリアクリレート等からなる高分子物質である。ま
た多孔質無機担体として適当なものは、シリカ、アルミ
ナ、マグネシア、酸化チタン、ガラス、ケイ酸塩、カオ
リンの如き合成もしくは天然の物質であり、多糖又はそ
の誘導体との親和性を良くするために表面処理を行って
も良い。表面処理の方法としては、有機シラン化合物を
用いたシラン化処理やプラズマ重合による表面処理法等
がある。The carrier may be a porous organic carrier or a porous inorganic carrier, preferably a porous inorganic carrier. Suitable porous organic carriers are polymeric materials such as polystyrene, polyacrylamide, polyacrylate, and the like. Also suitable as porous inorganic carriers are synthetic or natural substances such as silica, alumina, magnesia, titanium oxide, glass, silicates, and kaolin, which can be used to improve compatibility with polysaccharides or derivatives thereof. Surface treatment may also be performed. Examples of surface treatment methods include silanization using an organic silane compound and surface treatment using plasma polymerization.
なお光学分割に多糖又はその誘導体を用いる場合、化学
的に同じ誘導体であってもその分子量、分子量分布、結
晶化度、配向性などの物理的状態により分離の特性が変
化する場合があるので、目的とする用途にふされしい形
状を与えた後で、あるいは与える過程において熱処理、
エツチングその他の物理的、化学的処理を加えることが
できる。又、しばしば原料となる多糖を不均一反応によ
って誘導体とした場合には、原料の有する高次構造をそ
のままもしくは一部保存し、均一反応で合成したものと
化学的に同一であっても異なった分離特性を有する場合
がある。When using polysaccharides or their derivatives for optical resolution, the separation characteristics may change depending on their physical states such as molecular weight, molecular weight distribution, crystallinity, and orientation, even if they are chemically the same derivatives. After or during the process of giving the shape suitable for the intended use, heat treatment,
Etching and other physical and chemical treatments can be applied. In addition, when raw material polysaccharides are often made into derivatives through heterogeneous reactions, the higher-order structure of the raw materials is preserved as is or in part, and even if they are chemically identical to those synthesized through homogeneous reactions, they can be made into derivatives. May have separation properties.
液体クロマトグラフィーあるいは薄層クロマトグラフィ
ーを行う場合の展開溶媒としては、該吸着剤を溶解又は
これと反応する液体を除いて特に制約はない。該吸着剤
を化学的方法で担体に結合したり、架橋により不溶化し
た場合には反応性液体を除いては制約はない。いうまで
もなく、展開溶媒によって化合物又は光学異性体の分離
特性は変化するので、各種の展開溶媒を検討することが
望ましい。There are no particular restrictions on the developing solvent for liquid chromatography or thin layer chromatography, except for a liquid that dissolves or reacts with the adsorbent. When the adsorbent is bonded to a carrier by a chemical method or made insolubilized by crosslinking, there are no restrictions except for the reactive liquid. Needless to say, the separation characteristics of compounds or optical isomers change depending on the developing solvent, so it is desirable to consider various developing solvents.
また薄層クロマトグラフィーを行う場合には0.1−〜
0.1mm程度の粒子から成る本発明の吸着剤と必要で
あれば少量の結合剤より成る0、1mlll−100I
II11の厚さの層を支持板上に形成すれば良い。In addition, when performing thin layer chromatography, 0.1-~
0.1ml-100I consisting of the adsorbent of the present invention consisting of particles of about 0.1mm and a small amount of binder if necessary
A layer having a thickness of II11 may be formed on the support plate.
本発明で用いる多糖系吸着剤が前記のリグナン類の光学
分割に有効である理由は明らかではない。本発明におけ
る環状構造を有するリグナン類のフレキシビリティの低
い骨格と二個の芳香族環が不斉構造の識別を容易ならし
めることは想像にかたくない。しかし、特に多糖エステ
ルを主成分とする吸着剤の場合には、分離対象物質の極
性基との相互作用が重要な役割を果たすと考えられてお
り、エーテル結合或いはラクトン環を有するリグナン類
の分割にそれらが効果的であることを説明できる。It is not clear why the polysaccharide-based adsorbent used in the present invention is effective for the optical resolution of lignans. It is not hard to imagine that the less flexible skeleton and two aromatic rings of the lignans having a cyclic structure in the present invention facilitate the identification of asymmetric structures. However, especially in the case of adsorbents whose main components are polysaccharide esters, interaction with the polar groups of the target substance is thought to play an important role, and the separation of lignans with ether bonds or lactone rings is be able to explain that they are effective.
本発明に用いる多糖系吸着剤はその原料が安価にしかも
多量に供給され、また化学的に安定であるなど、工業的
利用に適した特質を備えている。従って本発明の方法を
用いることによりラセミ体もしくは光学純度の低いリグ
ナン類を光学活性体として利用することが可能となった
。The polysaccharide adsorbent used in the present invention has characteristics suitable for industrial use, such as its raw materials being inexpensive and available in large quantities, and being chemically stable. Therefore, by using the method of the present invention, it has become possible to utilize racemic or lignans with low optical purity as optically active substances.
以下本発明を実施例によって具体的に説明するが、本発
明がこれらの実施例に限定されるものでないことは言う
までもない。EXAMPLES The present invention will be specifically explained below with reference to Examples, but it goes without saying that the present invention is not limited to these Examples.
実施例1
シリンガレシノール(1)のエナンチオマー混合物をセ
ルローストリスフェニルカルバメートを担持したシリカ
ゲルより成る充填剤を用いた液体クロマトグラフィーに
より光学分割した。Example 1 A mixture of enantiomers of syringaresinol (1) was optically resolved by liquid chromatography using a packing material made of silica gel supporting cellulose triphenyl carbamate.
そのクロマトグラムを第1図に示す。The chromatogram is shown in FIG.
尚、液体クロマトグラフィー用カラムとしては、セルロ
ーストリスフェニルカルバメートを、ジフェニルシラン
処理したシリカゲル上に約22重量%担持した充填剤を
長さ25CI11、内径0.46cmのステンレスカラ
ムに充填したものを用いた。The liquid chromatography column used was a stainless steel column with a length of 25 CI11 and an inner diameter of 0.46 cm, which was filled with a packing material in which about 22% by weight of cellulose trisphenyl carbamate was supported on silica gel treated with diphenylsilane. .
液体クロマトグラフィー条件は溶離液としてエタノール
を毎分1ml送液し、カラム温度は40℃に保った。検
出には紫外検出器を用いた。The liquid chromatography conditions were as follows: 1 ml of ethanol was pumped per minute as an eluent, and the column temperature was maintained at 40°C. An ultraviolet detector was used for detection.
第1図は実施例1の光学分割の結果を示すクロマトグラ
ムである。FIG. 1 is a chromatogram showing the results of optical resolution in Example 1.
Claims (1)
とする吸着剤を用いてクロマトグラフィーにより光学分
割することを特徴とするリグナン類の光学分割方法。A method for optically resolving lignans, which comprises optically resolving a mixture of optical isomers of lignans by chromatography using an adsorbent containing a polysaccharide derivative as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61205329A JP2579621B2 (en) | 1986-09-01 | 1986-09-01 | Optical resolution method of lignans |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61205329A JP2579621B2 (en) | 1986-09-01 | 1986-09-01 | Optical resolution method of lignans |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6360944A true JPS6360944A (en) | 1988-03-17 |
JP2579621B2 JP2579621B2 (en) | 1997-02-05 |
Family
ID=16505122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61205329A Expired - Lifetime JP2579621B2 (en) | 1986-09-01 | 1986-09-01 | Optical resolution method of lignans |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2579621B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0426639A (en) * | 1990-05-18 | 1992-01-29 | Daicel Chem Ind Ltd | Optical resolution of 2-cyclohexene-1-ol |
EP0527236A1 (en) * | 1991-03-04 | 1993-02-17 | Daicel Chemical Industries, Ltd. | Polysaccharide derivative, production thereof, and separating agent |
KR100457732B1 (en) * | 2002-07-20 | 2004-11-17 | 주식회사 렉스진바이오텍 | The preparation of asymmetric furofuranelignan compound |
CN114409667A (en) * | 2022-01-11 | 2022-04-29 | 西北农林科技大学 | Eucommia ulmoides leaf lignan compound, preparation method and application of eucommia ulmoides leaf lignan compound in neuroprotection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60108751A (en) * | 1983-11-18 | 1985-06-14 | Daicel Chem Ind Ltd | Separating agent |
JPS60226831A (en) * | 1984-04-02 | 1985-11-12 | Daicel Chem Ind Ltd | Separating agent |
-
1986
- 1986-09-01 JP JP61205329A patent/JP2579621B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60108751A (en) * | 1983-11-18 | 1985-06-14 | Daicel Chem Ind Ltd | Separating agent |
JPS60226831A (en) * | 1984-04-02 | 1985-11-12 | Daicel Chem Ind Ltd | Separating agent |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0426639A (en) * | 1990-05-18 | 1992-01-29 | Daicel Chem Ind Ltd | Optical resolution of 2-cyclohexene-1-ol |
EP0527236A1 (en) * | 1991-03-04 | 1993-02-17 | Daicel Chemical Industries, Ltd. | Polysaccharide derivative, production thereof, and separating agent |
EP0527236A4 (en) * | 1991-03-04 | 1994-03-23 | Daicel Chemical Industries, Ltd. | |
US5354852A (en) * | 1991-03-04 | 1994-10-11 | Daicel Chemical Industries, Ltd. | Polysaccharide derivative, process for producing the same, and separating agent |
KR100457732B1 (en) * | 2002-07-20 | 2004-11-17 | 주식회사 렉스진바이오텍 | The preparation of asymmetric furofuranelignan compound |
CN114409667A (en) * | 2022-01-11 | 2022-04-29 | 西北农林科技大学 | Eucommia ulmoides leaf lignan compound, preparation method and application of eucommia ulmoides leaf lignan compound in neuroprotection |
Also Published As
Publication number | Publication date |
---|---|
JP2579621B2 (en) | 1997-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS60226831A (en) | Separating agent | |
JPS60142930A (en) | Resolving agent | |
WO1991014708A1 (en) | Cyclodextrin polymerizates and process for producing them | |
JPS6360944A (en) | Optical resolution of lignans | |
Khairan et al. | Fabrication and evaluation of polyvinyl alcohol/corn starch/patchouli oil hydrogel films loaded with silver nanoparticles biosynthesized in Pogostemon cablin benth leaves’ extract | |
CN105148884B (en) | It is a kind of for quartz capillary chiral separation post of racemate resolution and preparation method thereof | |
JPS61267537A (en) | Optical resolution of oxycyclopentenone and derivative thereof | |
US7740758B2 (en) | Separating agent including polysaccharide derivative having a polycyclic structure | |
JPH01305091A (en) | Optical resolution of esters of ofloxacin | |
JPS60226833A (en) | Separating agent consisting of aromatic ester derivative of polysaccharide | |
JPS60108751A (en) | Separating agent | |
JPS61225138A (en) | Optical resolution of alcohol bearing atomic groups containing multiple bonds | |
JPH0693002A (en) | Separating agent consisting of alkoxy-substituted aromatic carbamate derivative of cellulose | |
EP1618949B1 (en) | Agent for separating optical isomers | |
JPS62198657A (en) | Optical resolution of sulfoxide | |
JPS61176538A (en) | Optical resolution of aralkyl alcohol | |
JPS6330444A (en) | Direct optical resolution of acetoin derivative | |
JP2506633B2 (en) | Method for optical resolution of cyclic carbonyl compounds | |
JPH0426639A (en) | Optical resolution of 2-cyclohexene-1-ol | |
JPH0680018B2 (en) | Separation agent | |
CN100400510C (en) | Method of separating optically active dihydroxy-heptenoic acid esters | |
JPS61191631A (en) | Optical resolution of dihydric alcohol | |
JPH01216954A (en) | Method for optically resolving alpha-hydroxy acid derivative | |
JPS63250327A (en) | Separating method | |
EP0970935B1 (en) | Method of separating optical isomers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |